Abstract
Smoking-related respiratory diseases are a major cause of morbidity and mortality. However, the relationship between smoking and respiratory disease has not been well-studied among ethnic minorities in general and among women in particular. The objective of this cross-sectional study was to evaluate the risk of airflow obstruction and to assess lung function among Hispanic and non-Hispanic White (NHW) female smokers in a New Mexico cohort. Participants completed a questionnaire detailing smoking history and underwent spirometry testing. Outcomes studied included airflow obstruction, selected lung function parameters, and chronic mucus hyper-secretion. Chi square, logistic, and linear regression techniques were utilized. Of the 1,433 eligible women participants, 248 (17.3%) were Hispanic; and 319 had airflow obstruction (22.3%). Hispanic smokers were more likely to be current smokers, and report lower pack-years of smoking, compared to NHW smokers (p < 0.05 for all analyses). Further, Hispanic smokers were at a reduced risk of airflow obstruction compared to NHW smokers, with an O.R. of 0.51, 95% C.I. 0.34, 0.78 (p = 0.002) after adjustment for age, BMI, pack-years and duration of smoking, and current smoking status. Following adjustment for covariates, Hispanic smokers also had a higher mean absolute and percent predicted post-bronchodilator FEV1/FVC ratio, as well as higher mean percent predicted FEV1 (p < 0.05 for all analyses). Hispanic female smokers in this New Mexico-based cohort had lower risk of airflow obstruction and better lung function than NHW female smokers. Further, smoking history did not completely explain these associations.
Abbreviations | ||
NHW: | = | Non-Hispanic White; |
NHANES III: | = | Third National Health and Nutrition Examination Survey; |
BMI: | = | Body mass index; |
ATS: | = | American Thoracic Society; |
ERS: | = | European Respiratory Society; |
FEV1: | = | Forced expiratory volume in 1 second; |
FVC: | = | Forced vital capacity; |
GOLD: | = | Global Initiative for Chronic Obstructive Lung Disease; |
COPD: | = | Chronic Obstructive Pulmonary Disease; |
CYP: | = | Cytochromal; |
U.S.: | = | United States; |
ETS: | = | Environmental tobacco smoke; |
AAT: | = | Alpha 1-antitrypsin |
Abbreviations | ||
NHW: | = | Non-Hispanic White; |
NHANES III: | = | Third National Health and Nutrition Examination Survey; |
BMI: | = | Body mass index; |
ATS: | = | American Thoracic Society; |
ERS: | = | European Respiratory Society; |
FEV1: | = | Forced expiratory volume in 1 second; |
FVC: | = | Forced vital capacity; |
GOLD: | = | Global Initiative for Chronic Obstructive Lung Disease; |
COPD: | = | Chronic Obstructive Pulmonary Disease; |
CYP: | = | Cytochromal; |
U.S.: | = | United States; |
ETS: | = | Environmental tobacco smoke; |
AAT: | = | Alpha 1-antitrypsin |